Patents by Inventor Joan Glick Bieler

Joan Glick Bieler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210252121
    Abstract: Antigen-specific T cells, including nave T cells, and including rare precursor cells are enriched and expanded in culture. Enrichment and expansion provides a platform for more effective immunotherapy by adoptive transfer, as well as platforms for personalizing immunotherapy by determining T cell reactivity with a library of candidate peptide antigens.
    Type: Application
    Filed: March 15, 2021
    Publication date: August 19, 2021
    Inventors: Jonathan Schneck, Karlo Perica, Joan Glick Bieler, Mathias Oelke
  • Patent number: 10987412
    Abstract: Antigen-specific T cells, including nave T cells, and including rare precursor cells are enriched and expanded in culture. Enrichment and expansion provides a platform for more effective immunotherapy by adoptive transfer, as well as platforms for personalizing immunotherapy by determining T cell reactivity with a library of candidate peptide antigens.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: April 27, 2021
    Assignee: The John Hopkins University
    Inventors: Jonathan Schneck, Karlo Perica, Joan Glick Bieler, Mathias Oelke
  • Patent number: 10098939
    Abstract: Antigen-specific T cells, including nave T cells, and including rare precursor cells are enriched and expanded in culture. Enrichment and expansion provides a platform for more effective immunotherapy by adoptive transfer, as well as platforms for personalizing immunotherapy by determining T cell reactivity with a library of candidate peptide antigens.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: October 16, 2018
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Jonathan Schneck, Karlo Perica, Joan Glick Bieler, Mathias Oelke
  • Publication number: 20180043003
    Abstract: Antigen-specific T cells, including nave T cells, and including rare precursor cells are enriched and expanded in culture. Enrichment and expansion provides a platform for more effective immunotherapy by adoptive transfer, as well as platforms for personalizing immunotherapy by determining T cell reactivity with a library of candidate peptide antigens.
    Type: Application
    Filed: October 23, 2017
    Publication date: February 15, 2018
    Inventors: Jonathan Schneck, Karlo Perica, Joan Glick Bieler, Mathias Oelke
  • Publication number: 20170246277
    Abstract: Antigen-specific T cells, including nave T cells, and including rare precursor cells are enriched and expanded in culture. Enrichment and expansion provides a platform for more effective immunotherapy by adoptive transfer, as well as platforms for personalizing immunotherapy by determining T cell reactivity with a library of candidate peptide antigens.
    Type: Application
    Filed: September 17, 2015
    Publication date: August 31, 2017
    Inventors: Jonathan Schneck, Karlo Perica, Joan Glick Bieler, Mathias Oelke